Surgery Safety Crisis: 38% of Patients Suffer Adverse Events

Immunotherapy drug pembrolizumab improves outcomes for patients with soft tissue sarcoma

Immunotherapy drug pembrolizumab improves outcomes for patients with soft tissue sarcoma - EurekAlert

Blood vessel-like coating could make medical devices safer for patients